Search results for " birth"

showing 10 items of 267 documents

Obstetric-Neonatal Care during Birth and Postpartum in Symptomatic and Asymptomatic Women Infected with SARS-CoV-2: A Retrospective Multicenter Study

2022

Este artículo se encuentra disponible en la siguiente URL: https://www.mdpi.com/1660-4601/19/9/5482 Este artículo de investigación pertenece a la colección "COVID-19 Research". En este artículo de investigación también participan: Laura Andreu-Pejó, Cristina Martínez-Porcar, Carmen Rodríguez Gonzálvez, Patricia Torrent-Ramos, Nieves Asensio-Tomás, Yolanda Herraiz-Soler, Ramon Escuriet y Desirée Mena-Tudela. This study analyses the obstetric–neonatal outcomes of women in labour with symptomatic and asymptomatic COVID-19. A retrospective, multicenter, observational study was carried out between 1 March 2020 and 28 February 2021 in eight public hospitals in the Valencian community (Spain). The…

COVID-19.Health Toxicology and MutagenesisCOVID-19; SARS-CoV-2; obstetric nursing; neonatal nursing; labour; obstetric*labourobstetric nursingEnvironmental Sciences & EcologyToxicologyNeonatología.labourCOVID-19 (Disease)neonatal nursingPregnancyobstetricHumansPregnancy Complications InfectiousNeonatology.Public Environmental & Occupational HealthRetrospective StudiesScience & Technology*obstetricSARS-CoV-2 (Virus)SARS-CoV-2Postpartum PeriodPublic Health Environmental and Occupational HealthInfant NewbornPregnancy OutcomeCOVID-19Pregnant women.Enfermería obstétrica.*SARS-CoV-2Infectious Disease Transmission Vertical*obstetric nursingHealth-promotion*neonatal nursingMujeres embarazadas.GinecologiaPremature BirthFemale*COVID-19Life Sciences & BiomedicineEnvironmental SciencesGynecologic nursing.
researchProduct

Effectiveness of progestogens to improve perinatal outcome in twin pregnancies : an individual participant data meta-analysis

2015

Background In twin pregnancies, the rates of adverse perinatal outcome and subsequent long-term morbidity are substantial, and mainly result from preterm birth (PTB). Objectives To assess the effectiveness of progestogen treatment in the prevention of neonatal morbidity or PTB in twin pregnancies using individual participant data meta-analysis (IPDMA). Search strategy We searched international scientific databases, trial registration websites, and references of identified articles. Selection criteria Randomised clinical trials (RCTs) of 17–hydroxyprogesterone caproate (17Pc) or vaginally administered natural progesterone, compared with placebo or no treatment. Data collection and analysis I…

Cervical pessaryAdultmedicine.medical_specialtymedicine.medical_treatmentPerinatal DeathDiseasesCervix UteriInfant Newborn DiseasesEnterocolitis NecrotizingPregnancy17 alpha-Hydroxyprogesterone CaproatemedicineHydroxyprogesteronesHumansTwin PregnancyProgesteroneBronchopulmonary DysplasiaCerebral HemorrhagePregnancyRespiratory Distress SyndromeRespiratory Distress Syndrome NewbornProgestogenIntravaginalObstetricsbusiness.industryEnterocolitisInfant NewbornObstetrics and GynecologyInfantTwinmedicine.diseaseNewbornCervical Length MeasurementClinical trialAdministration IntravaginalTreatment OutcomePremature birthCervical Length MeasurementRelative riskAdministrationPregnancy TwinPremature BirthFemaleProgestinsbusinessNecrotizing
researchProduct

Tobacco use in the third trimester of pregnancy and its relationship to birth weight. A prospective study in Spain

2015

Abstract Background Few studies have been carried out in Spain examining the use of tobacco amongst expectant mothers and its effect on birth weight. Aims To observe the proportion of expectant mothers who smoke during their pregnancy, and the impact of tobacco consumption on maternal and birth weight. We also aimed to identify the trimester of pregnancy in which tobacco use produced the greatest reduction in birth weight. Methods Prospective observational study in Spain. A random sampling strategy was used to select health centres and participant women. A total of 137 individuals were enrolled in the study. Exposure to tobacco was measured through a self-reported questionnaire. Regressions…

CessationAdultmedicine.medical_specialtyTobacco useACTIVE SMOKINGmedicine.medical_treatmentBirth weightPregnancy Trimester ThirdBIOMARKERSNursingThird trimester3rd trimesterBMIRandom AllocationPregnancyBirth weightMaternity and MidwiferyTobaccomedicineHumansMATERNAL SMOKINGEXPOSUREProspective StudiesProspective cohort studyObstetrics & Reproductive MedicineGESTATIONAL-AGEMETAANALYSISPregnancyScience & TechnologyObstetricsbusiness.industrySmokingInfant NewbornObstetrics and GynecologyObstetrics & GynecologyWOMEN11 Medical And Health SciencesInfant Low Birth Weightmedicine.diseasePREVALENCEBODY-MASS INDEXPregnancy ComplicationsSpainSmoking cessationObservational studyFemaleTobacco Smoke PollutionbusinessLife Sciences & Biomedicine
researchProduct

Epidemiologie von Hirntumoren im Kindesalter

2000

The German Childhood Cancer Registry (GCCR) was established in 1980. From 1980 to 1997 4,447 CNS tumours in children below 15 years of age have been reported to the registry. From 1988 to 1997 the average annual incidence was 2.5/100,000 children. This corresponds to 19.2% of the registered diseases. Compared with incidence rates reported from other developed countries one can estimate that there is about 25% underreporting of CNS tumours in the GCCR. This is in contrast to the relatively complete ascertainment of other childhood malignancies (above 95%). Based on 3012 incident cases from 1988 to 1997 the Kaplan-Meier-estimate of 5-year-survival probability is 65% for all CNS tumours and 54…

Childhood Cancer RegistryPediatricsmedicine.medical_specialtyPregnancybusiness.industryIncidence (epidemiology)Case-control studymedicine.diseaseAnnual incidenceCancer registryLow birth weightIncreased riskMedicineSurgeryNeurology (clinical)medicine.symptombusinessZentralblatt für Neurochirurgie
researchProduct

Risk factors associated with adverse events in neonates with peripherally inserted central catheter

2019

Abstract Background Peripherally inserted central catheters have become a priority in infants who require long-term intravenous therapy, but their use involves certain risks. Objective The aim of the study was to describe the occurrence of adverse events in newborns with peripherally inserted central catheters and to determine the risk factors associated with them. Methods A descriptive cross-sectional study was designed and performed. All neonates with peripherally inserted central catheters from October 1st, 2014 to September 30th, 2015 were included. The adverse events and sociodemographic and clinical variables related to neonates and analysed catheters were recorded. Results A total of…

Clinical variablesbusiness.industrymedicine.medical_treatmentPeripherally inserted central catheterExtravasation03 medical and health sciencesLow birth weight0302 clinical medicineIntravenous therapy030225 pediatricsAnesthesiamedicine030212 general & internal medicinemedicine.symptombusinessAdverse effectEnfermería Intensiva (English ed.)
researchProduct

Exposure to Gastric Acid Inhibitors Increases the Risk of Infection in Preterm Very Low Birth Weight Infants but Concomitant Administration of Lactof…

2018

Objective: To investigate whether exposure to inhibitors of gastric acidity, such as H2 blockers or proton pump inhibitors, can independently increase the risk of infections in very low birth weight (VLBW) preterm infants in the neonatal intensive care unit. Study design: This is a secondary analysis of prospectively collected data from a multicenter, randomized controlled trial of bovine lactoferrin (BLF) supplementation (with or without the probiotic Lactobacillus rhamnosus GG) vs placebo in prevention of late-onset sepsis (LOS) and necrotizing enterocolitis (NEC) in preterm infants. Inhibitors of gastric acidity were used at the recommended dosages/schedules based on the clinical judgmen…

ColonizationProton Pump InhibitorNeonatal intensive care unitAdministration OralHistamine H2 AntagonistProbioticGastroenterologyPediatricsH2 blocker0302 clinical medicineRisk FactorsInfant Very Low Birth Weight030212 general & internal medicineCandidaVLBW neonateLacticaseibacillus rhamnosusGestational agePerinatology and Child HealthHistamine H2 AntagonistsItalyNecrotizing enterocolitismedicine.symptomInfectionInfant PrematureHumanmedicine.medical_specialtyBirth weightGastric AcidSepsis03 medical and health sciencesEnterocolitis NecrotizingIntensive Care Units NeonatalSepsis030225 pediatricsInternal medicinemedicineH2 blockersHumansDietary Supplementbusiness.industryRisk FactorProbioticsInfant NewbornProton Pump Inhibitorsmedicine.diseaseLow birth weightLactoferrinConcomitantDietary SupplementsPediatrics Perinatology and Child HealthVLBW neonatesCandida; Colonization; H2 blockers; Infection; Lactoferrin; VLBW neonates; Pediatrics Perinatology and Child HealthGastric acidLactobacillus rhamnosubusinessNew Zealand
researchProduct

Axial Length and Anterior Segment Alterations in Former Preterm Infants and Full-Term Neonates Analyzed With Scheimpflug Imaging.

2017

Purpose To compare the axial length and anterior segment alterations in preterm infants with and without retinopathy of prematurity with those of full-term infants. Methods The Wiesbaden Prematurity Study investigated 503 participants of former gestational age ≤32 weeks and gestational age ≥37 weeks now being aged 4 to 10 years. This study included 485 participants in the prospective controlled cross-sectional, hospital-based study with successful Pentacam Scheimpflug imaging. Anterior segment parameters, axial length measurements, and associated factors were analyzed. Results Corneal thickness did not differ between former preterm and full-term infants. Significant differences were found b…

Diagnostic ImagingMalePediatricsmedicine.medical_specialtyCorneal PachymetryTerm BirthBirth weightVisual AcuityGestational AgeAstigmatismRefraction Ocular03 medical and health sciences0302 clinical medicineAnterior Eye SegmentMedicineBirth WeightHumansProspective StudiesCorneal pachymetryChildFull Termmedicine.diagnostic_testbusiness.industryGestational ageRetinopathy of prematurityInfant Low Birth Weightmedicine.diseaseRefractive ErrorsOphthalmologyLow birth weightAxial Length EyeCross-Sectional Studies030221 ophthalmology & optometryTerm BirthFemalemedicine.symptombusiness030217 neurology & neurosurgeryInfant PrematureCornea
researchProduct

Niedermolekulares Heparin bei Frühgeborenen mit hereditären Risikofaktoren und venösen Thrombosen

2006

We describe the use of low molecular weight heparin to treat venous thrombosis in two very low-birth-weight pre-term infants (GA: 30 and 27 weeks) both with genetic and acquired prothrombotic risk factors. Initially both infants were treated with unfractionated heparin. Since in one infant no effect on the thrombus size was observed and in the other infant there was an increase in size, the anticoagulation therapy was switched to subcutaneously injected low molecular heparin (Enoxaparin). During enoxaparin therapy the anti-Xa-level was carefully monitored and dosages were adjusted accordingly. Partial resolution of the thrombosis was achieved in both infants during enoxaparin therapy. No cl…

Dosemedicine.drug_classbusiness.industryLow molecular weight heparinHeparinmedicine.diseaseThrombosisVenous thrombosisLow birth weightAnesthesiaPediatrics Perinatology and Child HealthmedicineGenetic riskmedicine.symptomThrombusbusinessmedicine.drugKlinische Pädiatrie
researchProduct

[Drugs use in pregnancy in the Valencia Region and the risk of congenital anomalies].

2017

Background Despite the potential risks of drug use during pregnancy, consumption has increased in recent decades. Objective To identify the risk of congenital anomalies (CA) associated with the use of drugs in primary care in pregnant women resident in the Valencia Region. Methods A case-control study, considering a case as a less than one year old live birth in 2009–2010, diagnosed with a CA and resident in the Valencia Region, obtained from the CA population-based registry. Controls were selected from the Metabolic Disease Registry, and the drugs prescribed and dispensed from the Integral Management of Pharmaceutical Services. Crude odds ratio (OR) was calculated with its 95% confidence i…

DrugAdultMalemedicine.medical_specialtyPreparación farmacéuticaEmbarazomedia_common.quotation_subjectPopulationLogistic regressionPediatricsRJ1-570Comunitat Valenciana03 medical and health sciencesYoung Adult0302 clinical medicinePregnancyRisk FactorsManagement of Technology and InnovationInternal medicineAmbulatory CareMedicineAnomalías congénitasHumans030212 general & internal medicineeducationmedia_commonPregnancyeducation.field_of_study030219 obstetrics & reproductive medicinebusiness.industryInfant NewbornAbnormalities Drug-InducedOdds ratioDexketoprofenmedicine.diseaseConfidence intervalSurgeryPregnancy ComplicationsSpainCase-Control StudiesFemalebusinessLive birthmedicine.drugFactores de riesgoAnales de pediatria (Barcelona, Spain : 2003)
researchProduct

A 5-year multicentre randomized controlled trial comparing personalized, frozen and fresh blastocyst transfer in IVF.

2020

Abstract Research question Does clinical performance of personalized embryo transfer (PET) guided by endometrial receptivity analysis (ERA) differ from frozen embryo transfer (FET) or fresh embryo transfer in infertile patients undergoing IVF? Design Multicentre, open-label randomized controlled trial; 458 patients aged 37 years or younger undergoing IVF with blastocyst transfer at first appointment were randomized to PET guided by ERA, FET or fresh embryo transfer in 16 reproductive clinics. Results Clinical outcomes by intention-to-treat analysis were comparable, but cumulative pregnancy rate was significantly higher in the PET (93.6%) compared with FET (79.7%) (P = 0.0005) and fresh embr…

Endometrial receptivity analysis (ERA)Adultmedicine.medical_specialtyPregnancy Rateendometrial receptivityFresh embryo transfer (ET)Fertilization in Vitrolaw.inventionRandomized controlled triallawPregnancyMedicineHumansBirth RateGynecologyCryopreservationPregnancyPersonalized embryo transfer (PET)Intention-to-treat analysisbusiness.industryBlastocyst TransferObstetrics and Gynecologymedicine.diseaseEmbryo TransferEmbryo transferPregnancy rateTreatment OutcomeReproductive MedicineFrozen embryo transfer (FET)embryonic structuresFemaleEndometrial receptivityWindow of implantation (WOI)Live birthbusinessInfertility FemaleLive BirthDevelopmental BiologyReproductive biomedicine online
researchProduct